<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8500749</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6174</journal-id>
<journal-id journal-id-type="nlm-ta">Neurosci Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurosci. Res.</journal-id>
<journal-title-group>
<journal-title>Neuroscience research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0168-0102</issn>
<issn pub-type="epub">1872-8111</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26869217</article-id>
<article-id pub-id-type="pmc">4884492</article-id>
<article-id pub-id-type="doi">10.1016/j.neures.2016.01.006</article-id>
<article-id pub-id-type="manuscript">NIHMS758460</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Dimensional assessment of behavioral changes in the cuprizone short-term exposure model for psychosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Kondo</surname>
<given-names>Mari A.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Fukudome</surname>
<given-names>Daisuke</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Dani R.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gallagher</surname>
<given-names>Michela</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kamiya</surname>
<given-names>Atsushi</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sawa</surname>
<given-names>Akira</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label> Department of Psychiatry, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Baltimore, MD 21287, USA</aff>
<aff id="A2"><label>b</label> Neurogenetics and Behavior Center, Department of Psychological and Brain Sciences, The Johns Hopkins University, Baltimore, Maryland 21218, USA</aff>
<author-notes>
<corresp id="CR1"><label>*</label> Corresponding author: <email>asawa1@jhmi.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>8</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>107</volume>
<fpage>70</fpage>
<lpage>74</lpage>
<!--elocation-id from pubmed: 10.1016/j.neures.2016.01.006-->
<abstract>
<p id="P1">Recent clinical studies have suggested a role for immune/inflammatory responses in the pathophysiology of psychosis. However, a mechanistic understanding of this process and its application for drug discovery is underdeveloped. Here we assessed our recently developed cuprizone short-term exposure (CSE) mouse model across behavioral domains targeting neurocognitive and neuroaffective systems. We propose that the CSE model may be useful for understanding the mechanism associating inflammation and psychosis, with applications for drug discovery in that context.</p>
</abstract>
<kwd-group>
<kwd>Cuprizone</kwd>
<kwd>cuprizone short-term exposure (CSE)</kwd>
<kwd>psychosis</kwd>
<kwd>behavior</kwd>
<kwd>inflammation</kwd>
<kwd>hippocampus</kwd>
<kwd>Research Domain Criteria (RDoC)</kwd>
<kwd>dimensional approach</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>